Currently, a 750mcg teriparatide injection formulation is accessible in AU but the access is limited . Generally, it’s recommended for patients with debilitating osteoporosis who exhibit an inability to respond adequately to, or cannot tolerate, alternative therapies. Regarding pricing can differ significantly depending on a pharmacy , coverage l